Nuwellis Inc. has announced that it received a Deficiency Notice from the Nasdaq Stock Market on June 18, 2025, indicating that the company is not in compliance with Nasdaq's minimum bid price requirement. The closing bid price for Nuwellis' common stock has been below $1.00 for 30 consecutive trading days, putting its listing on the Nasdaq Capital Market at risk. The company is not eligible for a compliance period due to a reverse stock split conducted within the past year, and its securities are currently subject to delisting unless a hearing is requested. Nuwellis plans to request a hearing and may implement another reverse stock split to regain compliance. However, there is no assurance that the company will be able to maintain its Nasdaq listing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.